Scynexis (SCYX) Non-Current Assets (2013 - 2026)
Scynexis (SCYX) posted Non-Current Assets of $14.9 million for Q1 2026, down 19.93% on a QoQ basis from $18.7 million in Q4 2025, and down 4.84% year-over-year from $15.7 million in Q1 2025.
Scynexis (SCYX) Non-Current Assets (2013 - 2026) Analysis & Trends
Scynexis' Non-Current Assets history runs 14 years deep, the most recent figure standing at $14.9 million for Q1 2026.
- Quarterly Non-Current Assets fell 4.84% year-over-year to $14.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $40.2 million (down 39.11% YoY) and the FY2025 annual result came in at $18.7 million, up 1.03% from the prior year.
- Non-Current Assets was $14.9 million for Q1 2026 at Scynexis, down from $18.7 million in the prior quarter.
- Across five years, Non-Current Assets topped out at $26.3 million in Q4 2023 and bottomed at $2.4 million in Q3 2025.
- A 5-year average of $13.3 million and a median of $13.2 million in 2024 frame the typical range for Non-Current Assets.
- Annual changes were most pronounced in 2023 — Non-Current Assets jumped 200.56% — and 2025, when it slumped 87.2%.
- Scynexis' Non-Current Assets stood at $8.7 million in 2022, then soared by 200.56% to $26.3 million in 2023, then retreated by 29.79% to $18.5 million in 2024, then increased by 1.03% to $18.7 million in 2025, then slipped by 19.93% to $14.9 million in 2026.
- Business Quant data shows SCYX's Non-Current Assets at $14.9 million in Q1 2026, $18.7 million in Q4 2025, and $2.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 36.78 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 26.33 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 8.68 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 79.20 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 3.84 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 15.70 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 25.92 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 2.47 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 9.64 Bn |
| 10 | Scynexis | 21.55 Mn | -15.20 Mn | - | 14.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 14.94 Mn |
| Dec 31, 2025 | 18.65 Mn |
| Sep 30, 2025 | 2.38 Mn |
| Jun 30, 2025 | 4.20 Mn |
| Mar 31, 2025 | 15.69 Mn |
| Dec 31, 2024 | 18.46 Mn |
| Sep 30, 2024 | 18.58 Mn |
| Jun 30, 2024 | 13.23 Mn |
| Mar 31, 2024 | 16.58 Mn |
| Dec 31, 2023 | 26.30 Mn |
| Sep 30, 2023 | 19.91 Mn |
| Jun 30, 2023 | 9.33 Mn |
| Mar 31, 2023 | 10.53 Mn |
| Dec 31, 2022 | 8.75 Mn |
| Sep 30, 2022 | 8.73 Mn |
| Jun 30, 2022 | 9.94 Mn |
| Mar 31, 2022 | 9.66 Mn |
| Dec 31, 2021 | 10.46 Mn |
| Sep 30, 2021 | 5.95 Mn |
| Jun 30, 2021 | 5.50 Mn |